Terminated PHASE4 INTERVENTIONAL 2-arm NCT03640650

Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

Sponsor: Advance Dosage Forms, Inc.

Interventions Dropless Therapy Usual Care

Updated 9 times since 2018 Last updated: Sep 14, 2021 Started: Aug 15, 2018 Primary completion: Mar 16, 2021 Completion: Mar 16, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

COVID-19 pandemic leading to uncertainty in the recruitement

This PHASE4 trial investigates Cataract Surgery and is currently terminated or withdrawn. Advance Dosage Forms, Inc. leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Oct 2021 — Jul 2024 [monthly]

Terminated PHASE4

Status: Recruiting → Terminated
Apr 2021 — Oct 2021 [monthly]

Recruiting PHASE4
Jan 2021 — Apr 2021 [monthly]

Recruiting PHASE4

▶ Show 4 earlier versions

Apr 2020 — Jan 2021 [monthly]

Recruiting PHASE4
Dec 2018 — Apr 2020 [monthly]

Recruiting PHASE4
Oct 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Sep 2018 — Oct 2018 [monthly]

Recruiting PHASE4

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Advance Dosage Forms, Inc.
Imprimis Pharmaceuticals, Inc.
PeriPharm

Data source: PeriPharm

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada